| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 76, 549-553, Copyright © 1993 by Endocrine Society
ARTICLES |
DL Hwang, CF Yen and JL Nadler
Department of Diabetes, Endocrinology and Metabolism, City of Hope National Medical Center, Duarte, California 91010.
Evidence suggests that magnesium (Mg) deficiency may play a key role in cardiovascular disease. In particular, Mg deficiency may lead to a potentiation of platelet aggregation. However, the factor(s) regulating intracellular-free Mg concentration ([Mg2+]i) in platelets is not known. We studied the effects of insulin on the changes of [Mg2+]i in human platelets. Preincubation of hirudinized platelet-rich plasma with insulin had a dose- and time-dependent effect on the increase of [Mg2+]i measured in Mag-fura-2-loaded cells with a fluorescence spectrophotometer. The maximal effect was achieved by incubation with 200 microU/mL insulin for 30 min. [Mg2+]i increased from the basal value of 266 +/- 23 mumol to 355 +/- 46 (SD, P < 0.001). In the presence of an antiinsulin receptor monoclonal antibody the effect of insulin was abolished suggesting that the Mg transport mechanism was an insulin-receptor mediated process. Furthermore, the insulin-stimulated Mg transport was inhibited by the addition of chelating agent ethylenediaminete-traacetate while the receptor binding was not altered. These findings suggest that insulin can translocate Mg from the extracellular space. Insulin alone had no effect on the changes of intracellular calcium (Ca) concentration using Ca-Fura-2 as a probe. In addition, glucose (5 mg/mL) was not effective in altering either the Mg or Ca concentration. Insulin (100 microU/mL) decreased thrombin-induced platelet aggregation (washed platelets resuspended in N-2- hydroxyethylpiperazine-N'-2-ethanesulfonic acid-Tyrode buffer). Similarly, the production of the proaggregatory eicosanoids thromboxane B2 was inhibited by insulin from 16 +/- 1 ng/10(8) platelets to 13 +/- 2 (P < 0.05). The results suggest that insulin, through the interactions with its receptors may be a key factor regulating, Mg transport in human platelets.
This article has been cited by other articles:
![]() |
J. Gu, H. Lu, A. G. Tsai, K. Schwarz, and M. R. Lieber Single-stranded DNA ligation and XLF-stimulated incompatible DNA end ligation by the XRCC4-DNA ligase IV complex: influence of terminal DNA sequence Nucleic Acids Res., September 27, 2007; 35(17): 5755 - 5762. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Delva, M Degan, M Trettene, and A Lechi Insulin and glucose mediate opposite intracellular ionized magnesium variations in human lymphocytes. J. Endocrinol., September 1, 2006; 190(3): 711 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Dorea Magnesium in Human Milk J. Am. Coll. Nutr., April 1, 2000; 19(2): 210 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. P. Romani, V. D. Matthews, and A. Scarpa Parallel Stimulation of Glucose and Mg2+ Accumulation by Insulin in Rat Hearts and Cardiac Ventricular Myocytes Circ. Res., February 18, 2000; 86(3): 326 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cefaratti, A. Romani, and A. Scarpa Differential Localization and Operation of Distinct Mg2+ Transporters in Apical and Basolateral Sides of Rat Liver Plasma Membrane J. Biol. Chem., February 11, 2000; 275(6): 3772 - 3780. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. L. Kao, A. R. Folsom, F. J. Nieto, J.-P. Mo, R. L. Watson, and F. L. Brancati Serum and Dietary Magnesium and the Risk for Type 2 Diabetes Mellitus: The Atherosclerosis Risk in Communities Study Arch Intern Med, October 11, 1999; 159(18): 2151 - 2159. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Barbagallo, L. J. Dominguez, M. R. Tagliamonte, L. M. Resnick, and G. Paolisso Effects of Glutathione on Red Blood Cell Intracellular Magnesium : Relation to Glucose Metabolism Hypertension, July 1, 1999; 34(1): 76 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Dominguez, M. Barbagallo, J. R. Sowers, and L. M. Resnick Magnesium Responsiveness to Insulin and Insulin-Like Growth Factor I in Erythrocytes from Normotensive and Hypertensive Subjects J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4402 - 4407. [Abstract] [Full Text] |
||||
![]() |
M. Barbagallo, R. K. Gupta, O. Bardicef, M. Bardicef, and L. M. Resnick Altered Ionic Effects of Insulin in Hypertension: Role of Basal Ion Levels in Determining Cellular Responsiveness J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1761 - 1765. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Sowers Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular Physiology Hypertension, March 1, 1997; 29(3): 691 - 699. [Full Text] |
||||
![]() |
R. M. Touyz and E. L. Schiffrin Angiotensin II and Vasopressin Modulate Intracellular Free Magnesium in Vascular Smooth Muscle Cells through Na+-dependent Protein Kinase C Pathways J. Biol. Chem., October 4, 1996; 271(40): 24353 - 24358. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |